Abstract

Venous thromboembolism (VTE) complicates one in 1000 pregnancies. The standard therapy in venous thromboembolism are anticoagulants, heparin, or warfarin. Uterine artery malformation is rare but can result in life-threatening bleeding which needs immediate intervention. A 33-year-old female, G2A1 at 36 weeks period of gestation, with h/o inferior vena cava (IVC) thrombus and uterine arterio-venous (AV) malformation, which was treated with uterine artery embolisation and Inferior vena cava (IVC) balloon angioplasty 3 years back, was successfully managed during her antenatal, intrapartum and postpartum period with anticoagulants at therapeutic doses. Both mother and baby were discharged in stable condition. The balance between prevention of thrombus formation and bleeding complication with the use of anticoagulants is critical in such patients. Successful management of both VTE and bleeding uterine artery malformation needs intensive monitoring and requires both anticoagulant and haemostatic therapy under close supervision of multidisciplinary team.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call